» Articles » PMID: 33712063

MiR-21: a Non-specific Biomarker of All Maladies

Overview
Journal Biomark Res
Publisher Biomed Central
Date 2021 Mar 13
PMID 33712063
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

miRNA-21 is among the most abundant and highly conserved microRNAs (miRNAs) recognized. It is expressed in essentially all cells where it performs vital regulatory roles in health and disease. It is also frequently claimed to be a biomarker of diseases such as cancer and heart disease in bodily-fluid based miRNA studies. Here we dissociate its contributions to cellular physiology and pathology from its potential as a biomarker. We show how it has been claimed as a specific predictive or prognostic biomarker by at least 29 diseases. Thus, it has no specificity to any one disease. As a result, it should not be considered a viable candidate to be a biomarker, despite its continued evaluation as such. This theme of multiple assignments of a miRNA as a biomarker is shared with other common, ubiquitous miRNAs and should be concerning for them as well.

Citing Articles

NAPTUNE: nucleic acids and protein biomarkers testing via ultra-sensitive nucleases escalation.

Hu T, Ke X, Yu Y, Feng H, Zhang S, Cui Y Nat Commun. 2025; 16(1):1331.

PMID: 39900931 PMC: 11790866. DOI: 10.1038/s41467-025-56653-9.


Diagnostic and Prognostic Accuracy of MiRNAs in Pancreatic Cancer: A Systematic Review and Meta-Analysis.

Hasani F, Masrour M, Khamaki S, Jazi K, Hosseini S, Heidarpour H J Cell Mol Med. 2025; 29(2):e70337.

PMID: 39855897 PMC: 11761000. DOI: 10.1111/jcmm.70337.


Sensitive and accurate photoluminescent-multiphonon resonant Raman scattering dual-mode detection of microRNA-21 via catalytic hairpin assembly amplification and magnetic assistance.

Wen X, Xue Z, Wang K, Li J, Ding Y, Wang G Mikrochim Acta. 2025; 192(1):49.

PMID: 39747697 DOI: 10.1007/s00604-024-06920-1.


miR-21-loaded bone marrow mesenchymal stem cell-derived exosomes inhibit pyroptosis by targeting MALT1 to repair chemotherapy-induced premature ovarian insufficiency.

Tang L, Yang Y, Yang M, Xie J, Zhuo A, Wu Y Cell Biol Toxicol. 2024; 41(1):3.

PMID: 39707056 PMC: 11662076. DOI: 10.1007/s10565-024-09946-6.


Microfluidic biosensors for biomarker detection in body fluids: a key approach for early cancer diagnosis.

Liu Z, Zhou Y, Lu J, Gong T, Ibanez E, Cifuentes A Biomark Res. 2024; 12(1):153.

PMID: 39639411 PMC: 11622463. DOI: 10.1186/s40364-024-00697-4.


References
1.
El-Hefny M, Fouad S, Hussein T, Abdel-Hameed R, Effat H, Mohamed H . Circulating microRNAs as predictive biomarkers for liver disease progression of chronic hepatitis C (genotype-4) Egyptian patients. J Med Virol. 2018; 91(1):93-101. DOI: 10.1002/jmv.25294. View

2.
Li J, Fu R, Yang L, Tu W . miR-21 expression predicts prognosis in diffuse large B-cell lymphoma. Int J Clin Exp Pathol. 2016; 8(11):15019-24. PMC: 4713624. View

3.
Cai E, Gao Y, Wei Z, Chen W, Yu P, Li K . Serum miR-21 expression in human esophageal squamous cell carcinomas. Asian Pac J Cancer Prev. 2012; 13(4):1563-7. DOI: 10.7314/apjcp.2012.13.4.1563. View

4.
Rauhut R, Lendeckel W, Tuschl T . Identification of novel genes coding for small expressed RNAs. Science. 2001; 294(5543):853-8. DOI: 10.1126/science.1064921. View

5.
Liu Y, Nie H, Zhang K, Ma D, Yang G, Zheng Z . A feedback regulatory loop between HIF-1α and miR-21 in response to hypoxia in cardiomyocytes. FEBS Lett. 2014; 588(17):3137-46. DOI: 10.1016/j.febslet.2014.05.067. View